Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2000-Year of the Biotechs! -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (420)	2/29/2000 10:57:00 PM
From: Don England	Respond to of 1142

enjoying your thots as always. love to see nabi rising. it's #5 in my portfolio at >5%, behind a very overweight position in gztc at >40%, with 15% in eln, 10% in ngen, and 8% in cyto. am now in 12 bios, having sold a lot of gztc on the way up. your opinion on diversification is gospel. up 151%ytd thanks to y'all. don

To: Arthur Radley who wrote (420)	2/29/2000 11:47:00 PM
From: Torben Noerup Nielsen	Read Replies (1) \| Respond to of 1142

Tex, Utter-Nonsense aside, NABI is an $11 stock. For today. But there's tremendous potential and I'd not be the least bit surprised to see three digits by the end of the year. That's not counting on mania; just real potential. I can see at least three potential products that could take them there. Although I've been the producer of the ``udder nonsense", that's mostly because I'm somewhat childish by nature and that's just the way it is. But I wouldn't be spending that much time being childish if I hadn't spent several times as long doing my homework. Disclaimer: my long position in NABI is into 5 figures. And that's shares. And I have every intention of averaging up on this one. I expect mild dips, but I do not see any basis for cratering. Thanks, Torben